Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 13776
Country/Region: Mozambique
Year: 2016
Main Partner: Center for Collaboration in Health
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $16,873,526 Additional Pipeline Funding: $1,400,000

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $2,070,230
Care: TB/HIV (HVTB) $327,506
Care: Pediatric Care and Support (PDCS) $185,836
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $20,000
Testing: HIV Testing and Counseling (HVCT) $664,506
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $1,039,477
Treatment: Adult Treatment (HTXS) $11,681,154
Treatment: Pediatric Treatment (PDTX) $884,817
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 808
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 3,235
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 1,087
GEND_GBV Number of people receiving post-GBV care 2017 4,299
HRH_PRE By Graduates: Other 2017 35
HRH_PRE Number of new HCW who graduated from a pre-service training institution or program as a result of PEPFAR-supported strengthening efforts, within the reporting period, by select cadre 2017 35
HRH_PRE Sum of Graduates disaggregates 2017 35
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 11,602
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 18,577
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 9,177
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 16,739
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 78,768
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 103,221
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 21,599
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 23,559
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 121,146
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 162,077
HTS_TST Service Delivery Point (Community): Index testing 2017 5,502
HTS_TST Service Delivery Point (Facility): Index testing 2017 32,845
HTS_TST Service Delivery Point (Facility): Other PITC 2017 273
HTS_TST Service Delivery Point (Facility): Other PITC 2017 365
HTS_TST Service Delivery Point (Facility): Outpatient 2017 72,709
HTS_TST Service Delivery Point (Facility): Outpatient 2017 25,919
HTS_TST Service Delivery Point (Facility): Pediatric 2017 1,436
HTS_TST Service Delivery Point (Facility): Pediatric 2017 1,046
HTS_TST Service Delivery Point (Facility): PMTCT 2017 18,623
HTS_TST Service Delivery Point (Facility): PMTCT 2017 67,586
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 857
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 277
HTS_TST Service Delivery Point (Facility): VCT 2017 27,248
HTS_TST Service Delivery Point (Facility): VCT 2017 28,537
HTS_TST Sum of Aggregated Age/Sex <15 2017 20,779
HTS_TST Sum of Aggregated Age/Sex <15 2017 35,316
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 100,367
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 126,780
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 121,146
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 162,096
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 461
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 1,246
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 374
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 1,165
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 6,547
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 13,132
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 3,375
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 6,146
PMTCT_ART Already on ART at beginning of current pregnancy 2017 655
PMTCT_ART Already on ART at beginning of current pregnancy 2017 4,318
PMTCT_ART New on ART 2017 990
PMTCT_ART New on ART 2017 6,470
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 19,299
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 73,004
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 916
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 7,075
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 415
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 3,181
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 33
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 252
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 46
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 348
PMTCT_EID Sum of Infant Age disaggregates 2017 1,331
PMTCT_EID Sum of Infant Age disaggregates 2017 10,256
PMTCT_STAT By: Known positives at entry 2017 664
PMTCT_STAT By: Known positives at entry 2017 4,362
PMTCT_STAT By: Number of new positives identified 2017 997
PMTCT_STAT By: Number of new positives identified 2017 6,536
PMTCT_STAT Number of new ANC and L&D clients 2017 19,494
PMTCT_STAT Number of new ANC and L&D clients 2017 73,741
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 19,299
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 73,004
PMTCT_STAT Sum of Positives Status disaggregates 2017 1,661
PMTCT_STAT Sum of Positives Status disaggregates 2017 10,898
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 762
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 4,953
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 412
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 2,663
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 1,173
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 7,616
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 1,173
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 7,616
TB_SCREENDX Screen Result: Screened Positive for TB 2017 15,511
TB_SCREENDX Screen Results: Screened Positive for TB 2017 1,988
TB_SCREENDX Screened for TB by Age/Sex: <15 Female 2017 901
TB_SCREENDX Screened for TB by Age/Sex: <15 Male 2017 901
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 14,978
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 117,810
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 8,066
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 63,439
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 6,327
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 6,327
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 24,832
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 193,877
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1,457
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 7,772
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 785
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 4,184
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 2,242
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 11,954
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 2,242
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 11,954
TX_CURR Age/Sex: <1 2017 70
TX_CURR Age/Sex: <1 2017 355
TX_CURR Aggregated Age/Sex: <15 Female 2017 1,069
TX_CURR Aggregated Age/Sex: <15 Female 2017 5,542
TX_CURR Aggregated Age/Sex: <15 Male 2017 1,069
TX_CURR Aggregated Age/Sex: <15 Male 2017 5,542
TX_CURR Aggregated Age/Sex: 15+ Female 2017 13,181
TX_CURR Aggregated Age/Sex: 15+ Female 2017 97,168
TX_CURR Aggregated Age/Sex: 15+ Male 2017 7,099
TX_CURR Aggregated Age/Sex: 15+ Male 2017 52,319
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 22,406
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 160,544
TX_CURR Sum of Aggregated Age/Sex <15 2017 2,138
TX_CURR Sum of Aggregated Age/Sex <15 2017 11,084
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 20,280
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 149,487
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 22,418
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 160,571
TX_NEW Aggregated Grouping by Age: <1 2017 70
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 355
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 2,061
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 3,793
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 23,137
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 355
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 2,061
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 2,042
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 12,458
TX_NEW By Age/Sex: <1 2017 355
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 6,538
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 39,694
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 6,545
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 39,717
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 5,331
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 33,374
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 3,998
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 25,030
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 435
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 2,224
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 2,041
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 13,401
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 435
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 2,224
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 1,100
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 7,216
TX_PVLS Numerator: Indication: Routine 2017 1,373
TX_PVLS Numerator: Indication: Routine 2017 6,996
TX_PVLS Numerator: Indication: Targeted 2017 2,625
TX_PVLS Numerator: Indication: Targeted 2017 18,034
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 579
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 2,960
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 579
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 2,960
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 2,720
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 17,867
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 1,466
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 9,618
TX_PVLS_den Denominator: Indication: Routine 2017 1,829
TX_PVLS_den Denominator: Indication: Routine 2017 9,327
TX_PVLS_den Denominator: Indication: Targeted 2017 3,502
TX_PVLS_den Denominator: Indication: Targeted 2017 24,047
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 220
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,541
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,774
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 22,070
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 220
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,541
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,495
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 11,884
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 4,696
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 37,014
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 6,707
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 46,744
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 309
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,941
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 3,961
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 27,878
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 309
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,941
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,134
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 15,013
Cross Cutting Budget Categories and Known Amounts Total: $1,631,515
Human Resources for Health $759,838
Gender: Gender Based Violence (GBV) $871,677
Post GBV Care
Implementation
Capacity building
Monitoring and Evaluation